Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|July 4, 2006
Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trialF D Anderson, William Gibbons, David Portman
Contraception|February 14, 2006
Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiolFreedolph D Anderson, William Gibbons, David Portman
Journal of the American Pharmacists Association : Japha|September 18, 2023
Pharmacist-driven deprescribing initiative in primary careEmily Rea, David Portman, Kara Ioannou, et al.
Journal of the American Pharmacists Association : Japha|August 11, 2024
Reprint of: Pharmacist-driven deprescribing initiative in primary careEmily Rea, David Portman, Kara Ioannou, et al.
Advances in Therapy|September 24, 2021
Variability in Contraceptive Clinical Trial Design and the Challenges in Making Comparisons Across TrialsDavid Portman, David L Eisenberg, Patty Cason, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 15, 2020
Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of MenopauseRobert L Reid, Denise Black, Christine Derzko, et al.
Menopause (New York, N.Y.)|October 24, 2013
Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopauseJoAnn V Pinkerton, Risa Kagan, David Portman, et al.
The Journal of Sexual Medicine|March 6, 2018
Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety StudyJames A Simon, Leonard Derogatis, David Portman, et al.
Pageof 3